## Clinical Assessment This patient presents with a locally advanced breast cancer (T3N1M0) based on: - Tumor size: 2 cm (T1/T2 range, but fixed to chest wall suggests T4) - Fixation to chest wall: T4 disease - Palpable matted axillary lymph nodes: N1 disease - No distant metastases: M0 ## Surgical Management Principles **Key Point:** Breast-conserving therapy (BCT) is contraindicated in T4 disease, skin involvement, or fixation to chest wall. Modified radical mastectomy (MRM) is the standard of care for locally advanced breast cancer. **High-Yield:** The presence of chest wall fixation (T4 disease) automatically excludes BCT as an option, regardless of tumor size or nodal status. ## Why Modified Radical Mastectomy? | Criterion | Assessment | Implication | | --- | --- | --- | | Tumor fixation | Yes (to chest wall) | Requires MRM | | Axillary involvement | Matted nodes (N1) | Requires ALND | | Distant metastases | None detected | M0 — suitable for surgery | | Skin involvement | Dimpling present | Confirms T4 status | **Clinical Pearl:** Skin dimpling indicates dermal involvement by tumor, which is part of T4 disease definition. This mandates mastectomy with adequate margins. ## Surgical Technique Modified radical mastectomy includes: 1. Total mastectomy (removal of breast tissue, nipple-areolar complex, and skin overlying the tumor) 2. Axillary lymph node dissection (Levels I, II, and III) 3. Preservation of pectoralis major and minor muscles (unlike classical radical mastectomy) **Mnemonic:** MRM = **M**astectomy + **R**emoval of **M**uscles (pectoralis major/minor are PRESERVED, unlike Halsted radical mastectomy) ## Why Not Other Options? - **BCT:** Contraindicated due to T4 disease (chest wall fixation) - **Simple mastectomy:** Inadequate — does not address axillary nodal disease; ALND is mandatory - **Neoadjuvant chemotherapy first:** While sometimes used in locally advanced disease to downstage, the primary surgical approach remains MRM with ALND; neoadjuvant is an adjunct, not a replacement for surgery in this context **High-Yield:** In India, MRM remains the gold standard for locally advanced breast cancer (Stage III) due to cost-effectiveness and proven oncologic outcomes comparable to BCT in early-stage disease. [cite:Sabiston Textbook of Surgery Ch 36] 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.